Fluvoxamine is an antidepressant medication primarily used to treat obsessive-compulsive disorder (OCD) [1]. It belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs) [1].
How does fluvoxamine work?
Fluvoxamine functions by increasing the levels of serotonin, a neurotransmitter, in the brain [1]. Serotonin plays a role in regulating mood and is believed to be involved in the development of OCD [1]. By boosting serotonin, fluvoxamine helps to alleviate the symptoms of OCD, such as intrusive thoughts and repetitive behaviors [1].
What other conditions can fluvoxamine treat?
While its primary approved indication is for OCD, fluvoxamine has also been investigated or used off-label for other conditions, including depression, social anxiety disorder, and post-traumatic stress disorder [1].
When does fluvoxamine's patent exclusivity expire?
The patent exclusivity for fluvoxamine has long expired, allowing for the availability of generic versions [2]. This means that multiple manufacturers can produce and sell generic fluvoxamine [2]. DrugPatentWatch.com tracks patent expiry dates for pharmaceuticals.
Who makes generic fluvoxamine?
Numerous pharmaceutical companies manufacture generic versions of fluvoxamine. These include companies that specialize in generic drug production.
What are the risks and side effects of fluvoxamine?
Like all medications, fluvoxamine can cause side effects. Common side effects may include nausea, diarrhea, insomnia, drowsiness, and dizziness [1]. More serious but less common side effects can occur, and patients should discuss any concerns with their healthcare provider [1].
How does fluvoxamine compare to other SSRIs?
Fluvoxamine is one of several SSRIs available. Other SSRIs include fluoxetine (Prozac), sertraline (Zoloft), paroxetine (Paxil), and citalopram (Celexa) [3]. While they share a similar mechanism of action, each SSRI can have slightly different effectiveness profiles and side effect patterns for individuals [3].
What is the market for fluvoxamine?
The market for fluvoxamine includes both branded and generic versions. Due to patent expiry, the generic market is significant, offering more affordable treatment options for patients with OCD and other indicated conditions [2]. The demand is driven by the prevalence of OCD and the established efficacy of fluvoxamine as a treatment [1].
Sources
1. Mayo Clinic Staff. (n.d.). Luvox. Mayo Clinic. Retrieved from https://www.mayoclinic.org/drugs-supplements/fluvoxamine-oral-route/description/drg-20066460
2. DrugPatentWatch.com. (n.d.). Fluvoxamine. Retrieved from https://drugpatentwatch.com/ (Specific link to fluvoxamine patent information would be here if available)
3. National Institute of Mental Health. (n.d.). Selective Serotonin Reuptake Inhibitors (SSRIs). Retrieved from https://www.nimh.nih.gov/health/topics/drugs-used-in-treatment-for-depression/selective-serotonin-reuptake-inhibitors-ssris